https://everef.net/type/2082Implants & Boosters / Implants / Attribute Enhancers / Implant Slot 010.0KGM

Genolution Core Augmentation CA-1

Market
StationSellBuy
Jita
Amarr
Rens
Dodixie
Hek
Maila
Basic
Volume1.0MTQ1.00 m3
Mass0.0KGM0.00 
Tech Level1.0Level1.00 
 Base Price800000.0Money800,000.00 
 Published1.0BooleanTrue
Cargo
Capacity0.0MTQ0.00 m3
Required skills
Booster
Charisma Modifier0.0attributePoints0.00 
Intelligence Modifier0.0attributePoints0.00 
Memory Modifier0.0attributePoints0.00 
Perception Modifier3.0attributePoints3.00 
Willpower Modifier0.0attributePoints0.00 
Other
Capacitor Modifier1.5Percentage1.50 
Implant Slot1.0Slot1.00 
 Genolution Set Bonus1.5Multiplier1.50 
Meta Level7.0Level7.00 
Power Output Bonus1.5Percentage1.50 
Capacity0.0MTQ0.00 m3
Mass0.0KGM0.00 
Volume1.0MTQ1.00 m3
radius1.01.00

Description

Traits
Slot 1
Primary Effect: +3 bonus to Perception
Secondary Effect: +1.5% bonus to powergrid and capacitor amount
Implant Set Effect: 50% bonus to the strength of all Genolution implant secondary effects

Development
The modestly titled “Core Augmentation” implant set was developed by Genolution with the assistance of implantation specialists and other leaders in the field of neural augmentation, some of whom have long been rumored to be SoCT alumni.

The CA-1 is a rarity in the often hyper-specialized industry of neural augmentations. It provides a dual function; tapping into both the occipital lobe for a perception boost, and also the neocortex, for improving the brain's handling of a ship's energy and capacitor needs. Like the infamous pirate implant sets found on capsuleer markets, each implant is also designed to work at higher levels when integrated into a neural implant network.

Though many in the augmentation industry initially questioned the agenda behind Genolution's entry into the implantation field, fears eventually subsided as the implant was shown to be one of the safest on record. Genolution went one step further to assuage fears however and vowed never to release the implant to open markets, providing only a single-run issue to capsuleers as a demonstration of the technology.